TaqMan-based multiplex PCR improves rapidity of sepsis diagnosis
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
Timely diagnosis is critical to survival in sepsis; data suggest that in general, mortality rate increases by 2% for every hour delay in antimicrobial therapy, and in severe sepsis, there is a ~7.6% decline in survival per hour from hypotension onset without antimicrobials.
TaqMan-based multiplex real-time PCR is a novel, highly rapid/accurate method for diagnosing sepsis.
Why this matters
Conventional blood culture methods for sepsis detection have low sensitivity, require ≤48-72 h for results, and are associated with false-positives.
TaqMan-based PCR allows for rapid, 2-h quantification without post-PCR processing needs, with 100% sensitivity (at concentration 1×103 CFU/mL), 52.2% specificity.
TaqMan-multiplex-RT-PCR validated using samples from 20 known blood samples (11 strains).
30 blood samples evaluated by Taq-multiplex-RT-PCR and blood culture.